Live updates

Rejected drug described as "cruise missile" for cancer

Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.

A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.

Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.


New pill to treat MS

The world's first pill for treating Multiple Sclerosis could be available on the NHS in England and Wales next month. The drug, Fingolimod, was trialled in Newcastle. The healthcare guidance body NICE has changed its mind and decided it should be prescribed for certain cases